Virtus LifeSci Biotech Clinical Trials ETF Rating $19.55 +0.47 (+2.46%) Closing price 05/2/2025 04:10 PM EasternExtended Trading$19.57 +0.02 (+0.10%) As of 05/2/2025 05:06 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsRatingsBuy This Stock Virtus LifeSci Biotech Clinical Trials ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.BBC Aggregate RatingModerate Buy 2.96Holdings in BBC have an aggregate rating of Moderate Buy based on 399 analyst ratings issued in the past year covering 49 companies (52.4% of the portfolio).BBC Aggregate Price Target$19.55High Prediction$19.55Average Prediction$19.55Low Prediction$19.55Holdings in BBC have an aggregate price target of $19.55 and a range of $19.55 to $19.55 covering 49 companies (52.4% of the portfolio).BBC Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy32 Buy rating(s)Moderate Buy16 Moderate Buy rating(s)Hold1 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Virtus LifeSci Biotech Clinical Trials ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 49 BBC Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings1.78%SLNOSoleno Therapeutics$75.23+0.3%4.6718 of 5 stars3.20$104.67 39.1%10Upcoming EarningsNews CoveragePositive News1.69%SMMTSummit Therapeutics$27.90+13.1%2.9052 of 5 stars3.00$37.40 34.1%10Earnings ReportAnalyst ForecastAnalyst RevisionNews CoverageGap Up1.65%ANABAnaptysBio$21.19-2.4%2.5769 of 5 stars2.70$33.63 58.7%10Upcoming EarningsAnalyst ForecastNews CoveragePositive News1.56%AKROAkero Therapeutics$44.87-1.0%3.7956 of 5 stars3.00$76.29 70.0%9Upcoming EarningsNews CoveragePositive News1.45%LQDALiquidia$15.83+13.2%2.9101 of 5 stars3.11$26.63 68.2%9News CoveragePositive NewsHigh Trading Volume1.42%XERSXeris Biopharma$4.71+5.1%3.5556 of 5 stars2.80$6.10 29.5%5Upcoming EarningsNews Coverage1.36%PTGXProtagonist Therapeutics$45.51+1.2%3.5021 of 5 stars3.00$65.44 43.8%9Upcoming EarningsNews CoveragePositive News1.32%ARQTArcutis Biotherapeutics$15.24+4.0%2.0949 of 5 stars2.83$18.80 23.4%6Upcoming Earnings1.30%MLYSMineralys Therapeutics$15.42+3.1%2.4595 of 5 stars3.00$33.00 114.0%3Upcoming EarningsShort Interest ↑News Coverage1.25%MRUSMerus$44.19-2.8%3.4107 of 5 stars3.13$85.31 93.0%16Upcoming EarningsShort Interest ↓Analyst RevisionNews Coverage1.20%CVACCureVac$3.56+4.7%3.8628 of 5 stars3.00$14.00 293.3%2Analyst ForecastGap Up1.12%ZYMEZymeworks$12.96+0.6%2.8053 of 5 stars2.88$21.00 62.0%8Upcoming EarningsAnalyst RevisionNews CoveragePositive News1.09%SVRASavara$3.40+4.3%1.7665 of 5 stars2.83$8.83 159.8%6Upcoming EarningsNews Coverage1.08%ABUSArbutus Biopharma$3.59-0.6%2.1293 of 5 stars3.00$5.50 53.2%4News CoveragePositive News1.06%QUREuniQure$14.77-1.5%2.2759 of 5 stars2.82$38.80 162.7%11Upcoming EarningsShort Interest ↑Analyst RevisionNews Coverage1.06%SNDXSyndax Pharmaceuticals$13.73-0.7%3.6304 of 5 stars2.90$36.20 163.7%10Upcoming EarningsNews CoveragePositive News1.05%XENEXenon Pharmaceuticals$38.28+0.5%2.6389 of 5 stars3.00$56.78 48.3%10Upcoming EarningsAnalyst DowngradeOptions VolumeNews CoveragePositive NewsHigh Trading Volume1.04%DNTHDianthus Therapeutics$21.701.7995 of 5 stars3.22$54.33 150.4%9Upcoming EarningsNews CoveragePositive News1.03%BLTEBelite Bio$62.66+1.2%2.871 of 5 stars3.00$96.67 54.3%4News CoveragePositive News1.01%RNAAvidity Biosciences$32.20-1.5%2.7112 of 5 stars3.00$66.69 107.1%13Upcoming EarningsInsider TradePositive News1.00%ITOSiTeos Therapeutics$7.77+3.6%2.1027 of 5 stars3.00$25.50 228.2%4Earnings ReportUpcoming EarningsAnalyst ForecastAnalyst RevisionNews Coverage1.00%ABCLAbCellera Biologics$2.41-3.2%2.5725 of 5 stars2.67$7.50 211.2%3Upcoming EarningsPositive News1.00%CAPRCapricor Therapeutics$11.86-6.9%1.7512 of 5 stars3.00$34.50 190.9%6News Coverage0.99%CELCCelcuity$10.90+0.9%2.6724 of 5 stars3.14$30.17 176.8%7Short Interest ↓Analyst RevisionNews CoveragePositive News0.98%RVMDRevolution Medicines$40.72+0.2%3.8714 of 5 stars3.00$66.67 63.7%12Upcoming EarningsPositive News0.97%MNMDMind Medicine (MindMed)$6.93+5.2%2.4339 of 5 stars3.23$25.11 262.4%13Upcoming EarningsNews CoveragePositive NewsGap Up0.97%NUVLNuvalent$77.46+1.6%1.9404 of 5 stars2.90$115.50 49.1%10Upcoming EarningsNews CoveragePositive News0.96%ETNB89bio$8.73+7.4%3.0503 of 5 stars3.00$27.25 212.1%9Earnings ReportUpcoming EarningsAnalyst UpgradeAnalyst RevisionNews CoveragePositive NewsGap Up0.95%OMEROmeros$7.17+2.1%3.7457 of 5 stars2.80$22.50 213.8%50.94%LENZLENZ Therapeutics$29.52+2.2%2.0112 of 5 stars3.17$46.60 57.9%6News CoveragePositive News0.93%KROSKeros Therapeutics$14.65+0.5%3.1693 of 5 stars2.57$40.33 175.3%14Upcoming EarningsNews CoveragePositive News0.93%SANASana Biotechnology$1.89-0.5%1.967 of 5 stars2.86$10.80 471.4%7Upcoming Earnings0.93%RXRXRecursion Pharmaceuticals$5.70+3.6%2.3068 of 5 stars2.33$8.20 43.9%6Upcoming EarningsGap Up0.92%VERVVerve Therapeutics$5.19-5.6%3.8384 of 5 stars3.00$25.75 396.1%6Positive News0.92%RGNXREGENXBIO$10.40+5.8%4.4835 of 5 stars2.83$31.63 204.1%6Upcoming EarningsNews CoveragePositive News0.92%CMPSCOMPASS Pathways$4.19+2.2%2.4824 of 5 stars3.00$20.20 382.1%6Upcoming EarningsNews CoveragePositive News0.91%CYTKCytokinetics$37.35-13.0%4.0599 of 5 stars2.89$76.88 105.8%19Upcoming EarningsAnalyst ForecastInsider TradeOptions VolumeNews CoverageGap DownHigh Trading Volume0.91%AVBPArriVent BioPharma$21.30+1.0%1.1078 of 5 stars3.17$39.00 83.1%6Short Interest ↑News CoverageGap Down0.91%PHVSPharvaris$18.37+2.9%2.2087 of 5 stars3.00$39.00 112.3%4Analyst ForecastAnalyst RevisionNews CoveragePositive News0.90%VIRVir Biotechnology$6.16+1.3%2.7032 of 5 stars2.86$33.57 445.0%7News Coverage0.90%NUVBNuvation Bio$2.46+8.4%3.6379 of 5 stars3.17$7.83 218.4%6Upcoming EarningsNews CoverageHigh Trading Volume0.89%EYPTEyePoint Pharmaceuticals$7.30+2.4%1.7397 of 5 stars3.00$26.63 264.7%9Upcoming EarningsNews CoveragePositive News0.89%MLTXMoonLake Immunotherapeutics$42.32+2.1%1.7346 of 5 stars3.00$80.50 90.2%8Upcoming EarningsAnalyst ForecastPositive News0.89%APGEApogee Therapeutics$40.12+2.3%2.2593 of 5 stars3.00$92.17 129.7%6News CoveragePositive News0.89%TRMLTourmaline Bio$16.30-8.7%2.7795 of 5 stars3.00$49.33 202.7%7Earnings ReportNews CoveragePositive NewsHigh Trading Volume0.88%VRDNViridian Therapeutics$13.62-0.9%1.3073 of 5 stars2.75$35.70 162.1%12Upcoming EarningsPositive News0.88%ACLXArcellx$65.55+0.0%1.8728 of 5 stars3.14$110.67 68.8%14Upcoming EarningsNews CoveragePositive News0.87%GPCRStructure Therapeutics$27.09-0.9%2.4346 of 5 stars3.00$78.63 190.2%9Upcoming EarningsAnalyst ForecastNews CoverageGap Up0.86%CNTACentessa Pharmaceuticals$13.61+0.8%2.6324 of 5 stars3.00$27.71 103.6%8News CoveragePositive NewsGap Up This page (NYSEARCA:BBC) was last updated on 5/3/2025 by MarketBeat.com Staff From Our PartnersThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredMost traders are panicking. We’re cashing inMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredElon Musk’s next move from the Oval Office?No one is closer to President Trump than Tesla CEO Elon Musk. He's been dubbed Trump's "first buddy." Tr...Weiss Ratings | SponsoredThe collapse has already startedThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Virtus LifeSci Biotech Clinical Trials ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Virtus LifeSci Biotech Clinical Trials ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy BBC Stock Free BBC Stock Alerts